mRNA-4157,Pembrolizumab
Moderna,Merck
['margaret', 'melanoma']
"this is an exciting advance in the field of cancer vaccines, an area notoriously tough to make progress in." - dr. margaret callahan, research director of our immunotherapeutics program, on new #mrna vaccine research for melanoma #cancerresearch #aacr23 
One of the world’s leading comprehensive cancer centers. To make an appointment: (833) 390-0294